Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care

Released: November 13, 2020 Expires: November 13, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by an independent education grant from Sanofi Genzyme. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — 1.0 Nursing Contact Hours Pharmacists — 1.0 Contact Hours (.1 CEUs) All other […]

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS RELEASE DATE: October 20, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that […]

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES RELEASE DATE: October 27, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with […]

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES RELEASE DATE: NOVEMEBER 11, 2020 VALID FOR CREDIT THROUGH: OCTOBER 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use […]

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited by the Consortium of Multiple Sclerosis Centers (CMSC) and Haymarket Medical Education (HME). Supported by an educational grant from Bristol Myers Squibb. Intended Audience Neurologists and other physicians, nurse practitioners, PAs, registered nurses, and pharmacists who collaborate to provide care for patients with MS Program […]

Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October 21, 2021 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and CMEology. This activity is supported by educational grants from Biogen, Bristol Myers Squibb, and EMD Serono. Target Audience This activity is designed to meet the educational needs of neurologists, […]

Differing Perspectives on Multiple Sclerosis Nursing Care

Release Date: October 20, 2020 Valid for Credit Through: October 31, 2021 Target Audience The target audience for this activity is nursing professionals involved in the management of patients with MS. Learning Objectives At the conclusion of this activity, learners should be better able to: Incorporate accumulated evidence, current guidelines, and emerging new clinical data […]

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

Release Date: July 31, 2020 Valid for Credit Through: July 31, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported in part by independent education grants from Alexion Pharmaceuticals and Genentech. Credit Available Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™ Nurses — 1.25 Nursing Contact Hours Pharmacists — 1.25 Contact […]

Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) — An ACTRIMS-ECTRIMS Virtual Satellite

Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) — An ACTRIMS-ECTRIMS Virtual Satellite Release Date: 10/07/2020 Valid for Credit through: 10/07/2021 Overview This case-based activity, originally held as a satellite symposium in conjunction with MSVirtual2020, is designed to present several key analytic and diagnostic […]

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September 30, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder TARGET AUDIENCE This activity has been designed to meet […]